Narayana Hrudayalaya Limited (NSE:NH)
India
· Delayed Price · Currency is INR 1,936.70
+2.60 (0.13%)
Jun 17, 2025, 10:30 AM IST
Narayana Hrudayalaya Revenue
In the fiscal year ending March 31, 2025, Narayana Hrudayalaya had annual revenue of 54.83B INR with 9.26% growth. Narayana Hrudayalaya had revenue of 14.75B in the quarter ending March 31, 2025, with 15.63% growth.
Revenue
54.83B
Revenue Growth
+9.26%
P/S Ratio
7.16
Revenue / Employee
4.70M
Employees
11,659
Market Cap
392.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 54.83B | 4.65B | 9.26% |
| Mar 31, 2024 | 50.18B | 4.89B | 10.79% |
| Mar 31, 2023 | 45.30B | 8.28B | 22.38% |
| Mar 31, 2022 | 37.01B | 11.17B | 43.24% |
| Mar 31, 2021 | 25.84B | -5.53B | -17.62% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
Narayana Hrudayalaya News
- 19 days ago - HSBC maintains reduce on Narayana Hrudayalaya, sees long gestation for India expansion - Business Upturn
- 22 days ago - Narayana Hrudayalaya shares rise nearly 4% after Q4 profit and revenue growth; stock nears 52-week high - Business Upturn
- 2 months ago - Narayana Hrudayalaya signs O&M agreement with Kammavari Sangham for 110-bed hospital in Bengaluru South - Business Upturn
- 3 months ago - Narayana Hrudayalaya’s subsidiary HCCI enters joint venture for cancer care in India - Business Upturn
- 4 months ago - Stocks to watch today on 21 Feb: Cipla, Senores, Narayana Hrudayalaya, Sanofi in pharmaceuticals and healthcare sector - Business Upturn
- 4 months ago - Narayana Hrudayalaya Ltd (NSE:NH) Q3 2025 Earnings Report Preview: What To Look For - GuruFocus
- 4 months ago - Key Results Today: Glenmark Pharma, ABFRL, GNFC, and Narayana Hrudayalaya among stocks in focus as Q3 results roll in - Business Upturn
- 4 months ago - Narayana Hrudayalaya shares surge 3% after lLand acquisition in South Bengaluru - Business Upturn